Risk Off As Covid Fears Overshadow Vaccine Elation

European markets ae pointing to a sharply lower open on the bell, following on from a steep sell off on Wall Street overnight.

Charts (6)

European markets ae pointing to a sharply lower open on the bell, following on from a steep sell off on Wall Street overnight. The vaccine euphoria of earlier in the week has well and truly faded, replaced by concerns over record high covid cases and more extensive lockdown conditions.
Covid cases hit record highs

In the UK the number of covid cases topped 33k. In the US the new number of daily infections covid cases hit a record 130,000 per day. The acceleration in cases points to more economically damaging restrictions to stem the spread of the virus. In the US the need for tighter restrictive measures comes as the fiscal stimulus talks have stalled. This leaves the US economy in a precarious position of potentially tighter, economically harmful restrictions without a rescue package to prop up the economy.

Here in the UK the overriding fear is that the one-month national lockdown simply won’t be enough. An extension of lockdown will deepen the economic scars left by Covid, lifting unemployment and making any form of economic recovery more drawn out and challenging.

Risk off trading
Risk aversion is dominating at the end of the week with investors pulling out of riskier assets such as stocks whilst flows into safe havens such as gold are on the rise. The rotation into value stocks and out of tech has been stopped in its tracks, with Nasdaq futures outperforming. This is a complete turnaround from earlier in the week when news of Pfizer’s vaccine candidate being 90% effective sent stocks surging to 8-month highs but dragged on US big tech.

The vaccine elation has been replaced with the realisation that the vaccine won’t be widely available for another 4 – 6 months. WIth covid cases surging, these 4 -6 months will be extremely challenging both from a health perspective and economically. So, whilst there is now light at the end of the tunnel, first there are a few very dark months which must be survived.

EZ GDP
Looking ahead, Eurozone Q3 GDP reading is expected to confirm a record 12.7% rebound. Although with France & Germany, the Eurozone’s two largest economies back in lockdown and Italy considering it, a double dip recession is almost certain, making Q3 numbers dated already.

FTSE Chart
  

Whilst the FTSE looks to extend losses from the previous session, it holds on to the majority of gains from earlier in the week. On the daily chart, the FTSE continues to trade firmly over the 5 month old descending trendline, and its 200 day moving average, as well as its 50 and 100 day moving average indicating that the positive bias remains intact.
Support can be seen at the 200 sma (6050) prior to 100 sma (6000). A fall below these levels & the descending trendline at 5950 could negate the current bullish break higher and see the FTSE resume its longer term bearish trend. On the flip side, resistance can be seen at 6500 June high. 



More from FTSE 100

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.